trimetazidine has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fu, B; Ma, S; Zhang, X | 1 |
Baksheev, VI; Kolomoets, NM; Uvaĭsova, KU | 1 |
Baksheev, VI; Kolomoets, NM; Uvaĭsova, IU; Zarubina, EG | 1 |
2 trial(s) available for trimetazidine and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
[Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin].
Topics: Coronary Disease; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Trimetazidine; Vascular Resistance; Vasodilator Agents | 2008 |
[Efficacy of long-term therapy with trimetazidine in patients with ischemic heart disease in combination with chronic obstructive pulmonary disease].
Topics: Aged; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Pulmonary Disease, Chronic Obstructive; Time Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2008 |
1 other study(ies) available for trimetazidine and Pulmonary Disease, Chronic Obstructive
Article | Year |
---|---|
Effects of trimetazidine in combination with bisoprolol in patients with chronic heart failure and concomitant chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis.
Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Chronic Disease; Drug Therapy, Combination; Heart Failure; Humans; Meta-Analysis as Topic; Observational Studies as Topic; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Research Design; Systematic Reviews as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2021 |